Bruyère Franck, Doumerc Nicolas
Urology Department, CHRU Tours.
PRES Centre Val de Loire, Université François Rabelais de Tours, Tours.
Curr Opin Urol. 2018 Mar;28(2):139-142. doi: 10.1097/MOU.0000000000000476.
Kidney transplantation is the preferred modality for the treatment of patients with end-stage renal disease. Robot-assisted kidney transplantation (RAKT) has been in use since 2002 to reduce morbidity in open kidney transplantation. The aim of this review is to highlight the most relevant publications on this challenging surgical topic.
Recent publications suggest that minimally invasive techniques in kidney transplantation, including RAKT, have shown promising results particularly with regard to complications and recovery, reducing postoperative pain and analgesic requirement with a better cosmetic result. Regarding complications, RAKT seems to be a safe surgical alternative to open kidney transplantation.
When performed by surgeons with robotic and kidney transplantation experience, RAKT is safe and reproducible in selected cases while maintaining excellent graft function. The ideal indication of RAKT seems to be for morbidly obese patients ineligible for open kidney transplantation. Further investigations need to confirm this promising data.
肾移植是终末期肾病患者的首选治疗方式。自2002年以来,机器人辅助肾移植(RAKT)已被用于降低开放肾移植的发病率。本综述的目的是突出关于这一具有挑战性的外科主题的最相关出版物。
最近的出版物表明,肾移植中的微创技术,包括RAKT,已显示出有前景的结果,特别是在并发症和恢复方面,减少了术后疼痛和镇痛需求,且美容效果更好。关于并发症,RAKT似乎是开放肾移植的一种安全的手术替代方法。
由有机器人手术和肾移植经验的外科医生进行时,RAKT在选定病例中是安全且可重复的,同时能保持良好的移植肾功能。RAKT的理想适应证似乎是不适于开放肾移植的病态肥胖患者。需要进一步研究来证实这些有前景的数据。